Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria

被引:2
|
作者
Tomita, Akihiro [1 ]
Shirasugi, Yukari [2 ]
Ito, Takahiko [3 ]
Tsurumi, Hisashi [4 ]
Naoe, Tomoki [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Tokai Univ Hosp, Dept Hematol & Oncol, Isehara, Kanagawa, Japan
[3] Gifu Social Insurance Hosp, Dept Hematol, Kani, Japan
[4] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan
关键词
Hemolytic Anemia; Paroxysmal Nocturnal Hemoglobinuria; Eculizumab; Hemoglobinuria; Intravascular Hemolysis;
D O I
10.1007/s00277-011-1368-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1139 / 1141
页数:3
相关论文
共 50 条
  • [1] Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria
    Akihiro Tomita
    Yukari Shirasugi
    Takahiko Ito
    Hisashi Tsurumi
    Tomoki Naoe
    Annals of Hematology, 2012, 91 : 1139 - 1141
  • [2] Predictors of hemoglobin response to eculizumab therapy in paroxysmal nocturnal hemoglobinuria
    DeZern, Amy E.
    Dorr, Donna
    Brodsky, Robert A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (01) : 16 - 24
  • [3] Paroxysmal nocturnal hemoglobinuria therapy with eculizumab: Spanish experience
    Lopez Rubio, Montserrat
    Morado, Marta
    Gaya, Ana
    Alonso Rosa, Dora
    Ojeda, Emilio
    Antonio Munoz, Juan
    Perez de Mendiguren, Begona
    Dolores Monteagudo, Maria
    Maria Duran, Jose
    Maria Fisac, Rosa
    Moreno, Damian
    Maria Villegas, Ana
    MEDICINA CLINICA, 2011, 137 (01): : 8 - 13
  • [4] Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
    Hill, Anita
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1467 - 1476
  • [5] Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
    Schrezenmeier, Hubert
    Hoechsmann, Britta
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 7 - 16
  • [6] Anticomplement 05 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
    Wong, Edwin K. S.
    Kavanagh, David
    TRANSLATIONAL RESEARCH, 2015, 165 (02) : 306 - 320
  • [7] Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab
    Roeth, Alexander
    Duehrsen, Ulrich
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (06) : 473 - 479
  • [8] Paroxysmal Nocturnal Hemoglobinuria A Complement-Mediated Hemolytic Anemia
    DeZern, Amy E.
    Brodsky, Robert A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (03) : 479 - +
  • [9] Eculizumab for the treatment of hemolytic paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and refractory myasthenia gravis
    Schubert, Joerg
    Menne, Jan
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (04): : 375 - 379
  • [10] Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria
    Oshiro, Hiroko
    Goi, Kumiko
    Akahane, Koshi
    Inukai, Takeshi
    Sugita, Kanji
    PEDIATRICS INTERNATIONAL, 2015, 57 (02) : e27 - e29